Equatorial Guinea vs Saudi Arabia: The number of people with susceptibility test result for rifampicin
Equatorial Guinea
492
in 2021
Saudi Arabia
591
in 2021
Equatorial Guinea rank
80th
Saudi Arabia rank
77th
The number of people with susceptibility test result for rifampicin over time
- Equatorial Guinea
- Saudi Arabia
How they compare
Saudi Arabia currently reports 591 against 492 in Equatorial Guinea, a difference of 99.
That makes Saudi Arabia's figure about 1.2 times Equatorial Guinea's.
Across all 5 years both countries report, Saudi Arabia has been ahead every year.
Equatorial Guinea ranks 80th and Saudi Arabia ranks 77th of 155 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.33 | 1,131 | 1,100 | Saudi Arabia |
| 2020s | 371 | 590.5 | 219.5 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Equatorial Guinea or Saudi Arabia?
- Saudi Arabia, at 591 against 492 in Equatorial Guinea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Equatorial Guinea and Saudi Arabia?
- 99, with Saudi Arabia ahead.
- How many years of comparable data are there for Equatorial Guinea and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Equatorial Guinea and Saudi Arabia rank globally for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 80th and Saudi Arabia ranks 77th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.